Neuropsychiatric Disorders and Treatment Market Overview

Widespread prevalence of neuropsychiatric disorders across the globe has generated massive demand for treatment. The number of individuals affected by neuropsychiatric disorders such as depression, alcohol-use disorders, schizophrenia and bipolar disorders is likely to grow further in view of the growing ageing population. Neuropsychiatric disorders are common in people more than 65 years. Rise in global geriatric population increases the prevalence of neuropsychiatric disorders and induces high demand for treatment and diagnosis.

Development in treatment and diagnosis methods have opened up new avenues for the growth of the market. In addition, the improving clinical availability of brain imaging modalities such as CT scan, MRI, and others have spurred the market growth.

Market Research Future (MRFR) has found out in its latest report that The Neuropsychiatric Disorders And Treatment Market is projected to reach USD 1,62,214 Million by 2030 at 11.5% CAGR during the forecast period 2022-2030. Neuropsychiatric disorders are mental illness which comprises the study of two fields of science – neurology, and psychiatry. It is one of the key areas of research in these two branches of medical science and is expected to gain momentum in the upcoming years.

There are several types of neuropsychiatric disorders, the root causes for some of which remains unknown to doctors and scholars. This gap between the incidences and treatments is likely to motivate the growth trajectory of the Neuropsychiatric Disorders and Treatment Market in the years to come. Investments are expected to observe an upswing in the forthcoming years for addressing the rising need for diagnosis. It is likely to push the growth curve of the market to exhibit a steeper rise over the assessment period.Large-scale prevalence of these disorders in conjunction with the ever-increasing patient population is anticipated to propel the expansion of the neuropsychiatric disorders and treatment market in the foreseeable future. In addition, rising cases of depression and other such psychiatric disorders are further expected to favor the growth of the market in the forthcoming years. On the contrary, the lack of clinical trial data coupled with long term treatment is poised to check the expansion of the neuropsychiatric disorders and treatment market through the projection period.

Massive investment in Research & development activities by pharmaceutical giants for the development of treatment of neuropsychiatric disorders has fostered the growth of the market. However, despite decades of research, the results of such research remain elusive which might constrain the growth of the market. Other market deterrents include long term treatment and lack of clinical trial data for neuropsychiatric diseases.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1281

Neuropsychiatric Disorders and Treatment Market Segmentation

The global neuropsychiatric disorders and treatment market has been segmented based on disorders, treatments, and end users. By disorders, the market has been segmented into degenerative diseases, neurotic disorders, psychosis and others. By treatment, the market has been segmented into shock treatment, drug treatment, and others. By end users, the market has been segmented into hospitals, clinics, research centers and others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/neuropsychiatric-disorders-treatment-market-1281

Neuropsychiatric Disorders and Treatment Market Regional Analysis

North America, Europe, Asia Pacific, and the Middle East & Africa are the key markets for neuropsychiatric disorders and treatment market. North America is the largest market for neuropsychiatric disorders and treatment market due to the overriding burden of neuropsychiatric disorders which results in a large number of deaths per year.

Europe is the second largest market for neuropsychiatric disorders, led by the regions of Iceland, Norway, and Switzerland. Huge population suffering from mental disorders and augmenting need for better treatment is boosting the market in Europe.

Asia Pacific neuropsychiatric disorders and treatment market is advancing at a rapid pace. The rise in geriatric population, persistently improving healthcare sector and raising awareness in the region favors the growth of the market in Asia Pacific.

The Middle East & Africa market accounts for the least share of the market. Lack of awareness and limited availability of advanced treatment options, especially in the Africa region acts an impediment to the growth of the market. However, improving healthcare sector in the Middle East is expected to provide impetus to the growth of the Middle East & Africa market.

Competitive Landscape

Eli Lilly (US), Universal Health Services Inc. (US), Wyeth (US), AstraZeneca (UK), Pfizer (US), Astellas Pharma Inc. (Japan), Biogen (US), Boehringer Ingelheim GmbH (Germany), Otsuka Holdings Co. Ltd (Japan), GlaxoSmithKline (UK), Bristol-Meyer Squibb (US), Johnson & Johnson (US) are the notable players operating in the global neuropsychiatric disorders and treatment market.

Industry Updates

  • In June 2018, the world's first neurosurgical robotic system for bilateral stereotactic neurosurgery was designed by a mechanical engineering team of the Hong Kong University. The breakthrough technology can assist in the treatment of variety of neuropsychiatric disorders.
  • In April 2018, Biogen and Ionis Pharmaceuticals entered into a partnership to work on a 10-year, $1 Billion-plus project to develop neuropsychiatric drugs. Biogen will be responsible for non-clinical studies, clinical development, commercialization and manufacturing. In addition, Biogen will have the option to license therapies coming out of this collaboration.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com